These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 2-methoxyestradiol impacts on amino acids-mediated metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor. Gorska-Ponikowska M; Perricone U; Kuban-Jankowska A; Lo Bosco G; Barone G J Cell Physiol; 2017 Nov; 232(11):3030-3049. PubMed ID: 28262924 [TBL] [Abstract][Full Text] [Related]
4. Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens. Leblanc K; Sexton E; Parent S; Bélanger G; Déry MC; Boucher V; Asselin E Int J Oncol; 2007 Feb; 30(2):477-87. PubMed ID: 17203231 [TBL] [Abstract][Full Text] [Related]
5. The Major Heat Shock Proteins, Hsp70 and Hsp90, in 2-Methoxyestradiol-Mediated Osteosarcoma Cell Death Model. Gorska-Ponikowska M; Kuban-Jankowska A; Marino Gammazza A; Daca A; Wierzbicka JM; Zmijewski MA; Luu HH; Wozniak M; Cappello F Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963524 [TBL] [Abstract][Full Text] [Related]
6. Nitro-oxidative Stress Is Involved in Anticancer Activity of 17β-Estradiol Derivative in Neuroblastoma Cells. Gorska M; Kuban-Jankowska A; Milczarek R; Wozniak M Anticancer Res; 2016 Apr; 36(4):1693-8. PubMed ID: 27069147 [TBL] [Abstract][Full Text] [Related]
7. Neuronal nitric oxide synthase induction in the antitumorigenic and neurotoxic effects of 2-methoxyestradiol. Gorska M; Kuban-Jankowska A; Zmijewski MA; Gorzynik M; Szkatula M; Wozniak M Molecules; 2014 Aug; 19(9):13267-81. PubMed ID: 25170949 [TBL] [Abstract][Full Text] [Related]
8. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer. Osipo C; Meeke K; Cheng D; Weichel A; Bertucci A; Liu H; Jordan VC Int J Oncol; 2007 Feb; 30(2):509-20. PubMed ID: 17203234 [TBL] [Abstract][Full Text] [Related]
10. Silencing MED1 sensitizes breast cancer cells to pure anti-estrogen fulvestrant in vitro and in vivo. Zhang L; Cui J; Leonard M; Nephew K; Li Y; Zhang X PLoS One; 2013; 8(7):e70641. PubMed ID: 23936234 [TBL] [Abstract][Full Text] [Related]
11. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ. Mishra AK; Abrahamsson A; Dabrosin C Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755 [TBL] [Abstract][Full Text] [Related]
12. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine. Sui M; Jiang D; Hinsch C; Fan W Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437 [TBL] [Abstract][Full Text] [Related]
13. AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo. Ribas R; Pancholi S; Guest SK; Marangoni E; Gao Q; Thuleau A; Simigdala N; Polanska UM; Campbell H; Rani A; Liccardi G; Johnston S; Davies BR; Dowsett M; Martin LA Mol Cancer Ther; 2015 Sep; 14(9):2035-48. PubMed ID: 26116361 [TBL] [Abstract][Full Text] [Related]
14. ERβ-specific agonists and genistein inhibit proliferation and induce apoptosis in the large and small intestine. Schleipen B; Hertrampf T; Fritzemeier KH; Kluxen FM; Lorenz A; Molzberger A; Velders M; Diel P Carcinogenesis; 2011 Nov; 32(11):1675-83. PubMed ID: 21856997 [TBL] [Abstract][Full Text] [Related]
15. Binding of anterior gradient 2 and estrogen receptor-α: Dual critical roles in enhancing fulvestrant resistance and IGF-1-induced tumorigenesis of breast cancer. Li Z; Zhu Q; Chen H; Hu L; Negi H; Zheng Y; Ahmed Y; Wu Z; Li D Cancer Lett; 2016 Jul; 377(1):32-43. PubMed ID: 27063095 [TBL] [Abstract][Full Text] [Related]
16. 2-methoxyestradiol induces mitotic arrest, apoptosis, and synergistic cytotoxicity with arsenic trioxide in human urothelial carcinoma cells. Kuo KL; Lin WC; Ho IL; Chang HC; Lee PY; Chung YT; Hsieh JT; Pu YS; Shi CS; Huang KH PLoS One; 2013; 8(8):e68703. PubMed ID: 23967052 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790. Lanvin O; Bianco S; Kersual N; Chalbos D; Vanacker JM J Biol Chem; 2007 Sep; 282(39):28328-28334. PubMed ID: 17631492 [TBL] [Abstract][Full Text] [Related]
18. Anticancer Potential of Oleuropein, the Polyphenol of Olive Oil, With 2-Methoxyestradiol, Separately or in Combination, in Human Osteosarcoma Cells. Przychodzen P; Wyszkowska R; Gorzynik-Debicka M; Kostrzewa T; Kuban-Jankowska A; Gorska-Ponikowska M Anticancer Res; 2019 Mar; 39(3):1243-1251. PubMed ID: 30842154 [TBL] [Abstract][Full Text] [Related]
19. DNA strand breaks induced by nuclear hijacking of neuronal NOS as an anti-cancer effect of 2-methoxyestradiol. Gorska M; Kuban-Jankowska A; Zmijewski M; Marino Gammazza A; Cappello F; Wnuk M; Gorzynik M; Rzeszutek I; Daca A; Lewinska A; Wozniak M Oncotarget; 2015 Jun; 6(17):15449-63. PubMed ID: 25972363 [TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyestradiol Reverses the Pro-Carcinogenic Effect of L-Lactate in Osteosarcoma 143B Cells. Gorska-Ponikowska M; Kuban-Jankowska A; Daca A; Nussberger S Cancer Genomics Proteomics; 2017; 14(6):483-493. PubMed ID: 29109098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]